Veracyte Incผลกระทบต่อหุ้น 5
Veracyte Inc
West Pharmaceutical Services Inc
Solventum Corp.Solventum targets ~$500 million in annual cost savings via its Transform for the Future program and projects 18.3% earnings growth for 2026
3M Company3M holds a contractual option in 2027 to raise raw-material costs under its long-term supply agreement with Solventum, a potential headwind for Solventum but a possible benefit for 3M
Globus Medical